Your session is about to expire
← Back to Search
Supportive Oncology Care at Home for Pancreatic Cancer
N/A
Waitlist Available
Led By Ryan Nipp, MD, MPH
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
Study Summary
This trial looks at a new way of providing at-home care and monitoring for pancreatic cancer patients undergoing pre-operative treatment.
Eligible Conditions
- Pancreatic Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rates of completion
Rates of study enrollment
Secondary outcome measures
Change in psychological distress
Change in quality of life longitudinally throughout the study
Change in symptom burden longitudinally throughout the study
+13 moreOther outcome measures
Dose intensity
Number of cycles of chemotherapy completed
Number of emergency department visits
+13 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Supportive Oncology Care at HomeExperimental Treatment1 Intervention
The Supportive Oncology Care at Home intervention entails the following:
patient-reported symptoms, vital sign, and weight monitoring with appropriate triggers for phone calls and home visits by Medically Home based on a clinician-derived algorithm
scheduled nursing visits for intravenous (IV) hydration during the course of chemotherapy;
regular communication with oncology clinicians regarding care delivered at home to ensure continuity of care.
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,929 Previous Clinical Trials
13,198,245 Total Patients Enrolled
Stand Up To CancerOTHER
51 Previous Clinical Trials
40,234 Total Patients Enrolled
Ryan Nipp, MD, MPHPrincipal InvestigatorMassachusetts General Hospital
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger